ESP Live! National Meeting Highlights
Release Date: May 06, 2011
Expiration Date: May 06, 2012
Expected time to complete this activity as designed: 60 minutes
This educational initiative provides video highlights from annual pain and addiction medicine congresses. Sessions will include interesting and sometimes controversial thought leader discussions of the clinical implications on the latest development and research topics in pain management.
This activity is designed for physicians, pharmacists, physician assistants, nurses, and other health care professionals who have an interest in enhancing their clinical skills in pain management.
Upon completion of this educational activity, participants should be able to:
- Identify emerging legal, ethical, and regulatory issues impacting the practice of pain management
- Summarize the latest developments in new opioid formulations and delivery systems, including those currently available as well as those in development
- Differentiate acute pain transitioning to chronic pain and mechanisms and factors responsible for the transition
- Summarize key developments and practice challenges related to opioid REMS programs currently in place and potential future initiatives
This activity is eligible for credit through May 6, 2012. After this date, the activity will expire and no further credit will be awarded. There are no fees for participating in or receiving credit for this online educational activity.
Follow these steps to earn CME/CE credit:
1. Read the target audience, learning objectives, and author disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content.
3. Complete the educational content online as designed or printed out.
4. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score of 70% on the test and complete the Activity Evaluation to provide feedback for future programming.
Certificates may be printed immediately after successfully completing the online self-assessment post-activity and evaluation.
Jeffrey A. Gudin, MD – Moderator
Pain Management Center
Englewood Hospital and Medical Center
Englewood, New Jersey
Dr. Jeffrey A. Gudin received his medical degree from Albany Medical College in Albany, New York. Following a transitional internship in surgery, medicine, and anesthesiology at St. Barnabas Medical Center in Livingston, New Jersey, he completed a residency in anesthesiology at Yale University School of Medicine. He continued his training with an extended postdoctoral fellowship in pain medicine at the Yale Center for Pain Management, where he was actively involved in research and teaching. He is currently co-director of the Pain Management Center at Englewood Hospital and Medical Center in New Jersey, an affiliate of the Mount Sinai School of Medicine. Dr. Gudin is board certified in pain medicine and anesthesiology, and is board eligible in addiction medicine.
An active speaker in the field of pain management, Dr. Gudin has been interviewed on various television news channels, including CBS, and other national news networks. Dr. Gudin has also been quoted in The New York Times and various regional newspapers in New Jersey and Connecticut. His clinical and research focus includes pain management, regional anesthesia, and preemptive analgesia, as well as increasing clinician awareness of pain assessment and management.
Alex Cahana, MD, FIPP
Chief, Pain Medicine
Department of Anesthesiology and Pain Medicine
University of Washington Medical Center
Dr. Alex Cahana received his medical degree from Tel Aviv University in his native Israel and completed an advanced clinical fellowship in interventional and palliative pain management at Vanderbilt University, Nashville. In addition to his medical degree, he holds a masters degree in bioethics and medical humanities from the Faculty of Theology, University of Lausanne, Switzerland. Dr. Cahana served as director of the Postoperative and Interventional Pain Program at Geneva University Hospitals in Switzerland. He is currently pain medicine chief at the University of Washington Medical Center, where he is also professor of anesthesiology and adjunct professor of radiology, and bioethics and humanities.
An internationally recognized anesthesiologist and pain specialist, Dr. Cahana is leading the creation of the National Pain Registry and is developing the Washington State Opioid Reform Initiative. He is associate editor of Pain Practice, Pain Medicine, and Pain Physician, is chair of the research committee of the American Academy of Pain Medicine, and is the assistant-at-large to the president of the World Institute of Pain. Dr. Cahana was awarded the Purple Heart as a medical officer in the Marine Corps. He speaks six languages (English, Hebrew, French, Arabic, Romanian, and Japanese).
Lora L. Brown, MD
Pain Management Specialist
Coastal Orthopedics Sports Medicine/Pain Management
Dr. Lora Brown received her medical degree from the University of Texas-San Antonio where she also completed her residency in anesthesia. She then completed her fellowship in pain management at the world-renowned Cleveland Clinic in Ohio. Dr. Brown is currently a pain management specialist with Coastal Orthopedics Sports Medicine/Pain Management in Bradenton, Florida.
Dr. Brown is board certified by the American Board of Anesthesiology, with certificates in pain medicine and anesthesiology, the American Board of Pain Medicine, and the American Board of Interventional Pain Physicians. She is the current president of the Florida chapter of American Society for Interventional Pain Physicians (ASIPP) where she serves on the Board of Directors. In addition, Dr. Brown serves on the Florida Governor’s Prescription Drug Monitoring Program, Implementation and Oversight Task Force.
As a pain management specialist, Dr. Brown has demonstrated documented success with all forms of spinal injections, facet injections, radiofrequency vertebroplasty (back fractures), minimally invasive disc procedures, and implantable nerve stimulators.
Ben A. Rich, JD, PhD
Professor and Chair, Bioethics
University of California–Davis School of Medicine
Dr. Ben Rich received his law degree from Washington University in St. Louis and eventually began his involvement in health care law. He later embarked on a career in academic bioethics, pursuing a PhD in philosophy at the University of Colorado, Boulder. He has faculty appointments at the University of California-Davis Departments of Internal Medicine, and Anesthesiology and Pain Medicine, as well as in the School of Law.
Dr. Rich serves as chair of the ethics committee of the American Pain Society (APS) and is a member of the ethics committee and the Council of Ethics of the American College of Legal Medicine. He has published extensively in medical, legal, and bioethics journals and textbooks on topics ranging from informed consent and advance directives to pain management and end-of-life care. Dr. Rich is on the editorial boards of the APS Bulletin, Cambridge Quarterly of Healthcare Ethics, Journal of Pain and Palliative Care Pharmacotherapy, and Pain Medicine. He received the Mayday Scholar's Award and the University of Colorado President's Fund for the Humanities Award. Dr. Rich is working to further develop the UC Davis Bioethics Program and its training of medical staff, students, and other professionals.
Sean Mackey, MD, PhD
Associate Professor of Anesthesia
(and of Neurology & Neurological Sciences, by courtesy)
Palo Alto, California
Dr. Sean Mackey received a PhD in electrical engineering and subsequently his medical degree at the University of Arizona in Tucson. He went on to Stanford University where he completed his anesthesiology residency, was chief resident, completed a fellowship in pain management, and then subsequently joined the faculty. While at Stanford, Dr. Mackey co-founded and directed the Regional Anesthesia Program. He is currently the chief of the Stanford Pain Management Division and the Pain Fellowship program director. He is also associate professor of anesthesia (and of neurology & neurological sciences by courtesy) at Stanford.
As director of the Stanford Systems Neuroscience and Pain Lab, Dr. Mackey’s primary research interest involves the use of advanced research techniques such as functional and structural neuroimaging, psychophysics, and neurobehavioral assessment to investigate the neural processing of pain and neuronal plasticity in patients with chronic pain. The research mission of the lab is to “Predict, Prevent and Alleviate Pain.” Dr. Mackey has served as principal investigator and investigator for multiple National Institutes of Health (NIH) and foundation grants to investigate novel analgesics for acute and chronic pain.
Dr. Mackey is a member of several professional organizations, on the Board of Directors for the American Academy of Pain Medicine, is a permanent member of the NIH National Institute on Drug Abuse (NIDA) study section, and serves on the editorial board and is a reviewer for multiple scientific journals. He has published over 60 peer-reviewed articles and book chapters. Dr. Mackey annually presents papers and lectures at both national and international pain medicine, neuroscience and anesthesiology meetings and has been interviewed extensively by the press.
Lynn R. Webster, MD, FACPM, FASAM
Co-Founder and Medical Director
Lifetree Clinical Research and Pain Clinic
Salt Lake City, Utah
Dr. Lynn Webster earned his medical degree from the University of Nebraska and completed his residency in the University of Utah’s Department of Anesthesiology. He is co-founder and medical director at Lifetree Clinical Research and Pain Clinic in Salt Lake City, Utah. He is also the co-founder of LifeSource, a non-profit foundation established in 2006 to provide education about pain-related issues as well as fund and conduct research. LifeSource’s first project, “Zero Unintentional Deaths,” was developed to educate physicians, chronic pain sufferers, and all communities about unintentional overdose deaths relating to methadone and other prescription medications.
Dr. Webster is board certified in anesthesiology and pain medicine with additional certification in addiction medicine; he is currently on the Board of Directors and serves as treasurer for the American Academy of Pain Medicine. He is past president of the Utah Academy of Pain Medicine and an active national spokesman for improving access to pain therapies.
Dr. Webster lectures extensively on the subject of preventing opioid abuse and criminal diversion in chronic pain patients. He has authored over 100 scientific abstracts, journal articles and recently published the book, Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners.
Scott M. Fishman, MD
Chief, Division of Pain Medicine
Vice Chair for Pain Medicine and Faculty Development
Professor of Anesthesiology and Pain Medicine
University of California, Davis
Dr. Scott Fishman received his medical degree from the University of Massachusetts Medical School, his formal clinical training in internal medicine and psychiatry, and completed pain medicine fellowship training through the Department of Anesthesia and Critical Care at Massachusetts General Hospital. Dr. Fishman has received board certification in internal medicine, psychiatry, pain medicine, and palliative medicine. He is chief of the Division of Pain Medicine, vice chair for pain medicine and faculty development, and professor of anesthesiology and pain medicine at the University of California, Davis.
Dr. Fishman is president and chairman of the board for the American Pain Foundation. He advocates for the field of pain medicine with consumers and lawmakers, and serves as a consultant to numerous government agencies. He has authored The War on Pain; Listening to Pain; Responsible Opioid Prescribing; and has co-authored The Massachusetts General Hospital Handbook of Pain Management; Essentials of Pain Medicine and Regional Anesthesia; Spinal Cord Stimulation: Implantation Techniques; and Bonica’s Management of Pain, 4th edition. He has also authored many peer-reviewed articles, book chapters, and other scholarly reviews. Dr. Fishman is senior editor of Pain Medicine and serves on the editorial boards of numerous medical journals. He lectures throughout the US on all aspects of pain and its treatment. In addition, Dr. Fishman has spoken about pain on the Today Show, Good Morning America, and the ABC Nightly News, and has been quoted in The New York Times, The Wall Street Journal, Time Magazine and Newsweek, and has served as the pain expert for Discoveryhealth.com.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-11-280-H01-P. Knowledge-based CPE activity.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 11-280-265
For information on applicability and acceptance of continuing nursing education credit for this activity, please consult your professional licensing board.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly the following disclosures were made.
Dr. Jeffrey Gudin has received honoraria related to speakers’ bureau activities from Cephalon, Inc., King Pharmaceuticals, Inc., Pfizer Inc., and Purdue Pharma L.P.
Dr. Lora Brown has received honoraria related to formal advisory activities and consultant fees from Vertos Medical Inc., as well as consultant fees from Nevro Corp.
Dr. Ben Rich has received honoraria as a consultant from KOL, L.L.C.
Dr. Lynn Webster has received honoraria related to formal advisory activities and as a consultant from BioDelivery Sciences International, Inc., Cephalon, Inc., Covidien, King Pharmaceuticals, Inc., PharmacoFore, and Purdue Pharma L.P. He has received grant support related to research activities from Collegium Pharmaceutical, Inc., Covidien, and King.
Dr. Alex Cahana, Dr. Sean Mackey and Dr. Scott Fishman have disclosed no relevant financial relationships with the grantor or any other commercial company whose products and services may be related to their presentations.
Planning Committee Disclosures
The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, Bronwyn Boyes, PharmD, director, and Alan Vogenberg, RPh, FASCP, clinical advisor, have no relevant financial relationships.
Adam J. Carinci, MD, was the clinical reviewer for this activity and has no relevant financial relationships.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Drs. Gudin, Cahana, Brown, Rich, Mackey, Webster, and Fishman indicated that their presentations would not include the discussion of unlabeled uses of commercial products or investigational/unapproved products not yet approved by the FDA for any use in the United States
MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at email@example.com.
Provided by MediCom Worldwide, Inc.
This activity is supported by independent educational grants from Cephalon, Inc. and Purdue Pharma, L.P.
©2011 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.